219 related articles for article (PubMed ID: 17455337)
1. Solving molecular crystal structures from X-ray powder diffraction data: the challenges posed by gamma-carbamazepine and chlorothiazide N,N,-dimethylformamide (1/2) solvate.
Fernandes P; Shankland K; Florence AJ; Shankland N; Johnston A
J Pharm Sci; 2007 May; 96(5):1192-202. PubMed ID: 17455337
[TBL] [Abstract][Full Text] [Related]
2. Quantitative phase analyses through the Rietveld method with X-ray powder diffraction data of heat-treated carbamazepine form III.
Antonio SG; Benini FR; Ferreira FF; Rosa PC; Paiva-santos Cde O
J Pharm Sci; 2011 Jul; 100(7):2658-64. PubMed ID: 21259240
[TBL] [Abstract][Full Text] [Related]
3. The determination of crystal structures of active pharmaceutical ingredients from X-ray powder diffraction data: a brief, practical introduction, with fexofenadine hydrochloride as example.
Brüning J; Schmidt MU
J Pharm Pharmacol; 2015 Jun; 67(6):773-81. PubMed ID: 25677117
[TBL] [Abstract][Full Text] [Related]
4. The principles underlying the use of powder diffraction data in solving pharmaceutical crystal structures.
Shankland K; Spillman MJ; Kabova EA; Edgeley DS; Shankland N
Acta Crystallogr C; 2013 Nov; 69(Pt 11):1251-9. PubMed ID: 24192168
[TBL] [Abstract][Full Text] [Related]
5. Crystallographic characterization of several erythromycin A solvates: the environment of the solvent molecules in the crystal lattice.
Henry R; Zhang GG
J Pharm Sci; 2007 May; 96(5):1251-7. PubMed ID: 17455320
[TBL] [Abstract][Full Text] [Related]
6. Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values.
Javadzadeh Y; Mohammadi A; Khoei NS; Nokhodchi A
Acta Pharm; 2009 Jun; 59(2):187-97. PubMed ID: 19564143
[TBL] [Abstract][Full Text] [Related]
7. Structure determination of forms I and II of phenobarbital from X-ray powder diffraction.
Platteau C; Lefebvre J; Hemon S; Baehtz C; Danede F; Prevost D
Acta Crystallogr B; 2005 Feb; 61(Pt 1):80-8. PubMed ID: 15659860
[TBL] [Abstract][Full Text] [Related]
8. Powder diffraction crystallography of molecular solids.
Harris KD
Top Curr Chem; 2012; 315():133-77. PubMed ID: 21952843
[TBL] [Abstract][Full Text] [Related]
9. Crystal morphologies and polymorphs in tolbutamide microcrystalline powder.
Li Destri G; Marrazzo A; Rescifina A; Punzo F
J Pharm Sci; 2013 Jan; 102(1):73-83. PubMed ID: 23042550
[TBL] [Abstract][Full Text] [Related]
10. Structural study of polymorphs and solvates of finasteride.
Othman A; Evans JS; Evans IR; Harris RK; Hodgkinson P
J Pharm Sci; 2007 May; 96(5):1380-97. PubMed ID: 17455354
[TBL] [Abstract][Full Text] [Related]
11. Structure determination of seven phases and solvates of Pigment Yellow 183 and Pigment Yellow 191 from X-ray powder and single-crystal data.
Ivashevskaya SN; van de Streek J; Djanhan JE; Brüning J; Alig E; Bolte M; Schmidt MU; Blaschka P; Höffken HW; Erk P
Acta Crystallogr B; 2009 Apr; 65(Pt 2):212-22. PubMed ID: 19299877
[TBL] [Abstract][Full Text] [Related]
12. Structure prediction, disorder and dynamics in a DMSO solvate of carbamazepine.
Cruz-Cabeza AJ; Day GM; Jones W
Phys Chem Chem Phys; 2011 Jul; 13(28):12808-16. PubMed ID: 21670828
[TBL] [Abstract][Full Text] [Related]
13. Isostructurality among solvates of cabazitaxel: X-ray structures and new solvates preparation.
Xu W; Gong N; Yang S; Zhang N; He L; Du G; Lu Y
J Pharm Sci; 2015 Apr; 104(4):1256-62. PubMed ID: 25675889
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine.
Lowes MM; Caira MR; Lötter AP; Van der Watt JG
J Pharm Sci; 1987 Sep; 76(9):744-52. PubMed ID: 11002813
[TBL] [Abstract][Full Text] [Related]
15. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies.
Seefeldt K; Miller J; Alvarez-Núñez F; Rodríguez-Hornedo N
J Pharm Sci; 2007 May; 96(5):1147-58. PubMed ID: 17455346
[TBL] [Abstract][Full Text] [Related]
16. Tris(hydroxymethyl) aminomethane salt of ramipril: synthesis, structural characterization from X-ray powder diffraction and stability studies.
Bhattacharya A; Chattopadhyay B; Chakraborty S; Roy BN; Singh GP; Godbole HM; Rananaware UB; Mukherjee AK
J Pharm Biomed Anal; 2012 Nov; 70():280-7. PubMed ID: 22877875
[TBL] [Abstract][Full Text] [Related]
17. Relationships between structural and thermal properties of anhydrous and solvated crystalline forms of brodimoprim.
Caira MR; Bettinetti G; Sorrenti M; Catenacci L
J Pharm Sci; 2007 May; 96(5):996-1007. PubMed ID: 17455357
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure and physicochemical characterization of ambazone monohydrate, anhydrous, and acetate salt solvate.
Muresan-Pop M; Braga D; Pop MM; Borodi G; Kacso I; Maini L
J Pharm Sci; 2014 Nov; 103(11):3594-3601. PubMed ID: 25187325
[TBL] [Abstract][Full Text] [Related]
19. Optimized multi-step NMR-crystallography approach for structural characterization of a stable quercetin solvate.
Filip X; Miclaus M; Martin F; Filip C; Grosu IG
J Pharm Biomed Anal; 2017 May; 138():22-28. PubMed ID: 28171789
[TBL] [Abstract][Full Text] [Related]
20. Clarithromycin form I determined by synchrotron X-ray powder diffraction.
Noguchi S; Miura K; Fujiki S; Iwao Y; Itai S
Acta Crystallogr C; 2012 Feb; 68(Pt 2):o41-4. PubMed ID: 22307251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
